For citations:

Milovanov S.S. Changing the first screening parameters for patients and their derivatives in Phase II–III clinical studies. Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice. 2023;(4):52-57. (In Russ.) https://doi.org/10.37489/2588-0519-2023-4-52-57